Notch signaling in lung cancer

References

• Rosti G, Bevilacqua G, Bidoli P, Portalone L, Santo A, Genestreti G. Small cell lung cancer. Ann. Oncol.17(Suppl. 2ii), 5–10 (2006).
   PubMedGoogle Scholar
• Govindan R, Page N, Morgensztern D et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J. Clin. Oncol.24(28), 4539–4544 (2006).
   PubMed Web of Science ®Google Scholar
• Shigematsu H, Lin L, Takahashi T et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J. Natl. Cancer Inst.97(5), 339–346 (2005).
   PubMed Web of Science ®Google Scholar
• Schrump DS, Giaccone D, Kelsey CR, Marks LB. Non-small-cell lung cancer. In: Cancer, Principles & Practice of Oncology (8th Edition). De Vita VT Jr, Lawrence TS, Rosemberg SA (Eds). Lippincot Williams & Wilkins, PA, USA, 896–946 (2008).
   Google Scholar
• Krug LM, Kris MG, Rosenzweig K, Travis WD. Small cell and other neuroendocrine tumors of the lung. In: Cancer, Principles & Practice of Oncology (8th Edition). De Vita VT Jr, Lawrence TS, Rosemberg SA (Eds). Lippincot Williams & Wilkins, PA, USA, 946–971 (2008).
   Google Scholar
• Weissman IL, Anderson DJ, Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol.17, 387–403 (2001).
   PubMed Web of Science ®Google Scholar
• Virchow RLK. Cellular Pathology. Berlin, Germany (1859).
   Google Scholar
• Giangreco A, Shen H, Reynolds SD, Stripp BR. Molecular phenotype of airway side population cells. Am. J. Physiol. Lung. Cell. Mol. Physiol.286(4), L624–L630 (2004).
   PubMed Web of Science ®Google Scholar
• Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR. Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am. J. Pathol.164(2), 577–588 (2004).
   PubMed Web of Science ®Google Scholar
• Giangreco A, Reynolds SD, Stripp BR. Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am. J. Pathol.161(1), 173–182 (2002).
   PubMed Web of Science ®Google Scholar
• Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell121(6), 823–835 (2005).
   PubMed Web of Science ®Google Scholar
• Meng RD, Shelton CC, Li YM et al. γ-secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. Cancer Res.69(2), 573–582 (2009).
   PubMed Web of Science ®Google Scholar
• Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer6(5), 963–968 (1953).
   PubMed Web of Science ®Google Scholar
• Wistuba II, Lam S, Behrens C et al. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst.89(18), 1366–1373 (1997).
   PubMed Web of Science ®Google Scholar
• Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cell20(1), 11–20 (2002).
   PubMed Web of Science ®Google Scholar
• Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res.67(10), 4827–4833 (2007).
   PubMed Web of Science ®Google Scholar
• Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell129(3), 465–472 (2007).
   PubMed Web of Science ®Google Scholar
• Brown JM. Tumor hypoxia in cancer therapy. Methods Enzymol.435, 297–321 (2007).
   PubMed Web of Science ®Google Scholar
• Milas L, Hittelman WN. Cancer stem cells and tumor response to therapy: current problems and future prospects. Semin. Radiat. Oncol.19(2), 96–105 (2009).
   PubMedGoogle Scholar
• Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature444(7120), 756–760 (2006).
   PubMed Web of Science ®Google Scholar
• Li Z, Bao S, Wu Q et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell15(6), 501–513 (2009).
   PubMed Web of Science ®Google Scholar
• Eliasz S, Liang S, Chen Y et al. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene29(17), 2488–2498 (2010).
   PubMed Web of Science ®Google Scholar
• Gustafsson MV, Zheng X, Pereira T et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev. Cell9(5), 617–628 (2005).
   PubMed Web of Science ®Google Scholar
• Androutsellis-Theotokis A, Leker RR, Soldner F et al. Notch signaling regulates stem cell numbers in vitro and in vivo. Nature442(7104), 823–826 (2006).
   PubMed Web of Science ®Google Scholar
• Harrison H, Farnie G, Howell SJ et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res.70(2), 709–718 (2010).
   PubMedGoogle Scholar
• Sullivan JP, Spinola M, Dodge M et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res.70(23), 9937–9948 (2010).
   PubMed Web of Science ®Google Scholar
• Miele L. Notch signaling. Clin. Cancer Res.12(4), 1074–1079 (2006).
   PubMed Web of Science ®Google Scholar
• Gordon WR, Vardar-Ulu D, Histen G, Sanchez-Irizarry C, Aster JC, Blacklow SC. Structural basis for autoinhibition of Notch. Nat. Struct. Mol. Biol.14(4), 295–300 (2007).
   PubMed Web of Science ®Google Scholar
• Chen Y, De Marco MA, Graziani I et al. Oxygen concentration determines the biological effects of NOTCH-1 signaling in adenocarcinoma of the lung. Cancer Res.67(17), 7954–7959 (2007).
   PubMed Web of Science ®Google Scholar
• Graziani I, Eliasz S, De Marco MA et al. Opposite effects of Notch-1 and Notch-2 on mesothelioma cell survival under hypoxia are exerted through the Akt pathway. Cancer Res.68(23), 9678–9685 (2008).
   PubMed Web of Science ®Google Scholar
• Weng AP, Millholland JM, Yashiro-Ohtani Y et al. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev.20(15), 2096–2109 (2006).
   PubMed Web of Science ®Google Scholar
• Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev.8(6), 707–719 (1994).
   PubMed Web of Science ®Google Scholar
• Hamada Y, Kadokawa Y, Okabe M, Ikawa M, Coleman JR, Tsujimoto Y. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development126(15), 3415–3424 (1999).
   PubMedGoogle Scholar
• Fan X, Mikolaenko I, Elhassan I et al. Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer Res.64(21), 7787–7793 (2004).
   PubMed Web of Science ®Google Scholar
• Ito T, Udaka N, Yazawa T et al. Basic helix–loop–helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development127(18), 3913–3921 (2000).
   PubMed Web of Science ®Google Scholar
• Donnem T, Andersen S, Al-Shibli K et al. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival. Cancer116(24), 5676–5685 (2010).
   PubMed Web of Science ®Google Scholar
• Sriuranpong V, Borges MW, Ravi RK et al. Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res.61(7), 3200–3205 (2001).
   PubMed Web of Science ®Google Scholar
• Nakakura EK, Sriuranpong VR, Kunnimalaiyaan M et al. Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. J. Clin. Endocrinol. Metab.90(7), 4350–4356 (2005).
   PubMed Web of Science ®Google Scholar
• Kunnimalaiyaan M, Yan S, Wong F, Zhang YW, Chen H. Hairy enhancer of split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells. Surgery138(6), 1137–1142 (2005).
   PubMed Web of Science ®Google Scholar
• Zheng Q, Qin H, Zhang H et al. Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549. Oncol. Rep.17(4), 847–852 (2007).
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhou JH, Deng ZH, Qu XH, Jiang HY, Liu Y. Expression and significance of Notch1, Jagged1 and VEGF in human non-small cell lung cancer. Zhong Nan Da Xue Xue Bao Yi Xue Ban32(6), 1031–1036 (2007).
   PubMedGoogle Scholar
• Westhoff B, Colaluca IN, D’Ario G et al. Alterations of the Notch pathway in lung cancer. Proc. Natl Acad. Sci. USA106(52), 22293–22298 (2009).
   PubMed Web of Science ®Google Scholar
• Chen Y, Li D, Liu H et al. Notch-1 signaling facilitates survivin expression in human non-small cell lung cancer cells. Cancer Biol. Ther.11(1), 14–21 (2011).
   PubMed Web of Science ®Google Scholar
• Baumgart A, Seidl S, Vlachou P et al. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer. Cancer Res.70(13), 5368–5378 (2010).
   PubMed Web of Science ®Google Scholar
• Dang TP, Gazdar AF, Virmani AK et al. Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. J. Natl Cancer Inst.92(16), 1355–1357 (2000).
   PubMed Web of Science ®Google Scholar
• Kees UR, Mulcahy MT, Willoughby ML. Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am. J. Pediatr. Hematol. Oncol.13(4), 459–464 (1991).
   PubMedGoogle Scholar
• Lee AC, Kwong YI, Fu KH, Chan GC, Ma L, Lau YL. Disseminated mediastinal carcinoma with chromosomal translocation (15;19). A distinctive clinicopathologic syndrome. Cancer72(7), 2273–2276 (1993).
   PubMed Web of Science ®Google Scholar
• Kubonishi I, Takehara N, Iwata J et al. Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res.51(12), 3327–3328 (1991).
   PubMed Web of Science ®Google Scholar
• Haruki N, Kawaguchi KS, Eichenberger S et al. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res.65(9), 3555–3561 (2005).
   PubMed Web of Science ®Google Scholar
• Konishi J, Yi F, Chen X, Vo H, Carbone DP, Dang TP. Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. Oncogene29(4), 589–596 (2010).
   PubMedGoogle Scholar
• Costa DB, Halmos B, Kumar A et al. BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations. PLoS Med.4(10), 1669–1679 (2007).
   PubMed Web of Science ®Google Scholar
• Konishi J, Kawaguchi KS, Vo H et al. γ-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res.67(17), 8051–8057 (2007).
   PubMed Web of Science ®Google Scholar
• Lin L, Mernaugh R, Yi F, Blum D, Carbone DP, Dang TP. Targeting specific regions of the Notch3 ligand-binding domain induces apoptosis and inhibits tumor growth in lung cancer. Cancer Res.70(2), 632–638 (2010).
   PubMed Web of Science ®Google Scholar
• Dang TP, Eichenberger S, Gonzalez A, Olson S, Carbone DP. Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice. Oncogene22(13), 1988–1997 (2003).
   PubMed Web of Science ®Google Scholar
• Moellering RE, Cornejo M, Davis TN et al. Direct inhibition of the NOTCH transcription factor complex. Nature462(7270), 182–188 (2009).
   PubMed Web of Science ®Google Scholar
• Wu Y, Cain-Hom C, Choy L et al. Therapeutic antibody targeting of individual Notch receptors. Nature464(7291), 1052–1057 (2010).
   PubMed Web of Science ®Google Scholar
• Riccio O, van Gijn ME, Bezdek AC et al. Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2. EMBO Rep.9(4), 377–383 (2008).
   PubMed Web of Science ®Google Scholar